Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ETHYOL | Cosette Pharmaceuticals | N-020221 DISCN | 1995-12-08 | 2 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
ethyol | New Drug Application | 2023-11-02 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
experimental radiation injuries | — | D011833 | — |
Code | Description |
---|---|
J0207 | Injection, amifostine, 500 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Head and neck neoplasms | D006258 | — | — | — | — | — | 1 | — | 1 |
Stomatitis | D013280 | EFO_1001904 | K12.1 | — | — | — | 1 | — | 1 |
Mucositis | D052016 | EFO_1001898 | — | — | — | — | 1 | — | 1 |
Drug common name | Amifostine |
INN | amifostine |
Description | Amifostine is an organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy. It has a role as a prodrug, a radiation protective agent and an antioxidant. It is a diamine and an organic thiophosphate. It is functionally related to a cysteamine. |
Classification | Small molecule |
Drug class | phosphoro-derivatives |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | NCCCNCCSP(=O)(O)O |
PDB | — |
CAS-ID | 20537-88-6 |
RxCUI | 1545987 |
ChEMBL ID | CHEMBL1006 |
ChEBI ID | 2636 |
PubChem CID | 2141 |
DrugBank | DB01143 |
UNII ID | ILA426L95O (ChemIDplus, GSRS) |